asiangames13th| Lepu Bio-B (02157.HK) plans to place up to a total of 51.17 million shares with a total raise of HK$234 million

Gelonghui May 17 丨 Lepu Bio-B (02157asiangames13th.HK) announced that on May 17, 2024, the company (as the issuer) entered into a placing agreement with the placing agents (CITIC Securities (600030) and HSBC), pursuant to which the placing agents have conditionally agreed to act as the company's agent to make every effort to promote a placing price of 4 per H share on a separate (rather than jointly or jointly and individually) basis.asiangames13th.58 HK$1.17 million placing shares.

The placing shares accounted for approximately 3.19% and 3.08% of the Company's entire existing issued H shares and the entire existing issued share capital as at the date of this announcement, respectively; and respectively accounted for the Company's enlarged issuance of placing shares pursuant to the Placing.asiangames13thapproximately 3.09% and 2.99% of all issued H shares and all issued share capital of the company.

Assuming all placing shares are fully placed, the total proceeds from the placing are expected to be approximately HK$234 million, and the total net proceeds from the placing are expected to be approximately HK$230 million. The company plans to use approximately 70% of the net proceeds from the placement for the research and development, clinical trials, registration and other work processes of the company's ADC candidate product; approximately 20% for the clinical trials and other work processes of the company's oncolytic virus candidate product CG0070; and approximately 10% to supplement the company's working capital and for general corporate purposes.